Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Enzyme-Linked Immunosorbent Assay

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cohort Profile Update: Survey of Health, Ageing and Retirement in Europe: Biomarker data for age-related health conditions.

medRxiv : the preprint server for health sciences·2026

Same author

Concurrent Anti-PR3 Immunoassay and cANCA Indirect Immunofluorescence Testing Provide Complementary Information for Clinical Laboratory Detection of Antineutrophil Cytoplasmic Antibodies.

The journal of applied laboratory medicine·2025

Same author

Historical Perspective on Antinuclear Antibody Testing.

The Journal of rheumatology·2025

Same author

Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis: Identifying Disease Risk Factors for Toxicity and Long-Term Outcomes in a Prospective, Single-Arm Trial.

Arthritis & rheumatology (Hoboken, N.J.)·2024

Same author

Dual diagnosis of <i>UQCRFS1</i>-related mitochondrial complex III deficiency and recessive <i>GJA8</i>-related cataracts.

Rare (Amsterdam, Netherlands)·2024

Same author

Anti-Rubella Immunoglobulin G Proficiency Testing Results Suggest Consistent Manufacturer Differences and Opportunity for Harmonization.

Archives of pathology & laboratory medicine·2024

Search research articles

Related Experiment Video

Updated: May 3, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

Tests for circulating immune complexes.

¹Department of Laboratory Medicine, University of Washington, Seattle, WA, USA.

Methods in Molecular Biology (Clifton, N.J.)

|February 6, 2014

Summary

Immune complexes are key in lupus. This study details methods to detect C1q-binding immune complexes and autoantibodies to C1q, crucial for understanding lupus nephritis.

Area of Science:

Immunology
Pathogenesis of Systemic Lupus Erythematosus (SLE)

Background:

Antigen-antibody complexes in tissues are central to lupus pathogenesis.
Immune complexes can form in situ or deposit from the bloodstream, triggering inflammation.
Measuring circulating immune complexes is vital for SLE research.

Purpose of the Study:

To describe methods for detecting C1q-binding immune complexes.
To outline a related test for autoantibodies to C1q.
To highlight the clinical relevance of these autoantibodies in lupus nephritis.

Main Methods:

Utilizing a C1q solid-phase assay to detect C1q-binding immune complexes.
Employing a related test to identify autoantibodies against C1q.
Focusing on assays involving complement proteins like C1q and C3.

More Related Videos

Multiplexed Fluorometric ImmunoAssay Testing Methodology and Troubleshooting

Multiplexed Fluorometric ImmunoAssay Testing Methodology and Troubleshooting

Published on: December 12, 2011

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate

Published on: January 17, 2018

Related Experiment Videos

Last Updated: May 3, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

Multiplexed Fluorometric ImmunoAssay Testing Methodology and Troubleshooting

Multiplexed Fluorometric ImmunoAssay Testing Methodology and Troubleshooting

Published on: December 12, 2011

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate

Published on: January 17, 2018

Main Results:

Established methods for quantifying C1q-binding immune complexes.
Developed assays for detecting autoantibodies to C1q, particularly those targeting the collagen-like region.
Linked autoantibodies to C1q with clinical and pathophysiological aspects of lupus nephritis.

Conclusions:

The C1q solid-phase assay and autoantibody tests are valuable tools for lupus research.
Detection of C1q-binding immune complexes and anti-C1q autoantibodies aids in understanding SLE.
These assays are particularly relevant for patients with lupus nephritis.